AMCGX
Price
$12.13
Change
-$0.07 (-0.57%)
Updated
Jun 22 closing price
Net Assets
305.19M
VMGMX
Price
$132.08
Change
+$0.31 (+0.24%)
Updated
Jun 22 closing price
Net Assets
33.76B
Interact to see
Advertisement

AMCGX vs VMGMX

AMCGX vs VMGMX Comparison Chart in %
View a ticker or compare two or three
VS
AMCGX vs. VMGMX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMCGX is a Hold and VMGMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMGMX has more cash in the bank: 33.8B vs. AMCGX (305M). VMGMX pays higher dividends than AMCGX: VMGMX (0.62) vs AMCGX (0.00). AMCGX was incepted earlier than VMGMX: AMCGX (33 years) vs VMGMX (15 years). AMCGX (1.94) is less costly to investors than VMGMX (0.07). AMCGX is a more actively managed with annual turnover of: 88.64 vs. VMGMX (17.00). AMCGX has a lower initial minimum investment than VMGMX: AMCGX (1000) vs VMGMX (3000). AMCGX annual gain was more profitable for investors over the last year : 21.27 vs. VMGMX (11.76). VMGMX return over 5 years is better than : 31.10 vs. AMCGX (-25.04).
AMCGXVMGMXAMCGX / VMGMX
Total Expense Ratio1.940.072,771%
Annual Report Gross Expense Ratio1.940.072,771%
Fund Existence33 years15 years-
Gain YTD8.7349.95288%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets305M33.8B1%
Annual Yield % from dividends0.000.62-
Returns for 1 year21.2711.76181%
Returns for 3 years63.1055.53114%
Returns for 5 years-25.0431.10-81%
Returns for 10 years56.55213.1327%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEMUX22.59N/A
N/A
Morgan Stanley Pathway Em Mkts Eq
MRICX26.84N/A
N/A
MFS Research International C
ICSSX16.85N/A
N/A
VY® Columbia Small Cp Val & InflectionS
ALVDX11.09N/A
N/A
American Century Focused Lg Cap Val R6
BRUMX18.35N/A
N/A
MFS Blended Research Value Equity R4